PMID- 21466746 OWN - NLM STAT- MEDLINE DCOM- 20120730 LR - 20161020 IS - 1469-5111 (Electronic) IS - 1461-1457 (Linking) VI - 14 IP - 10 DP - 2011 Nov TI - Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity. PG - 1367-76 LID - 10.1017/S1461145711000502 [doi] AB - Several studies have, with conflicting results, investigated the relationship between the Val(6)(6)Met polymorphism in brain-derived neurotrophic factor (BDNF) and attention deficit hyperactivity disorder (ADHD). We assessed longitudinal, quantitative phenotypes of hyperactivity-impulsivity and inattention in order to determine whether the Val(6)(6)Met polymorphism is associated with age-specific and/or persistent symptoms of hyperactivity-impulsivity and/or inattention in a community-based cohort of 1236 Swedish individuals for which ADHD symptom data were collected when the participants were aged 8-9, 13-14 and 16-17 yr. The Met allele was associated with symptoms of ADHD at ages 8-9 and 13-14 yr. A multivariate regression analysis revealed that the observed effect of the Met allele on ADHD symptoms reflects an influence on persistent hyperactivity-impulsivity symptoms. The present findings support the hypothesis that BDNF is involved in the pathogenesis of ADHD. The results highlight the importance of distinguishing between hyperactivity-impulsivity and inattention, respectively, and demonstrate the value of using a longitudinal approach in genetic studies of ADHD symptoms. FAU - Bergman, Olle AU - Bergman O AD - Department of Pharmacology, University of Gothenburg, Gothenburg, Sweden. olle.bergman@pharm.gu.se FAU - Westberg, Lars AU - Westberg L FAU - Lichtenstein, Paul AU - Lichtenstein P FAU - Eriksson, Elias AU - Eriksson E FAU - Larsson, Henrik AU - Larsson H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Twin Study DEP - 20110405 PL - England TA - Int J Neuropsychopharmacol JT - The international journal of neuropsychopharmacology JID - 9815893 RN - 0 (Brain-Derived Neurotrophic Factor) SB - IM MH - Adolescent MH - *Adolescent Behavior MH - Age Factors MH - Attention MH - Attention Deficit Disorder with Hyperactivity/diagnosis/*genetics/psychology MH - Brain-Derived Neurotrophic Factor/*genetics MH - Child MH - *Child Behavior MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - Humans MH - Impulsive Behavior/genetics MH - Logistic Models MH - Longitudinal Studies MH - Male MH - Multivariate Analysis MH - Odds Ratio MH - Phenotype MH - *Polymorphism, Single Nucleotide MH - Risk Assessment MH - Risk Factors MH - Surveys and Questionnaires MH - Sweden MH - Young Adult EDAT- 2011/04/07 06:00 MHDA- 2012/07/31 06:00 CRDT- 2011/04/07 06:00 PHST- 2011/04/07 06:00 [entrez] PHST- 2011/04/07 06:00 [pubmed] PHST- 2012/07/31 06:00 [medline] AID - S1461145711000502 [pii] AID - 10.1017/S1461145711000502 [doi] PST - ppublish SO - Int J Neuropsychopharmacol. 2011 Nov;14(10):1367-76. doi: 10.1017/S1461145711000502. Epub 2011 Apr 5.